Vaxon Biotech appoints CEO
Vaxon Biotech announces the appointment of company founder Dr. Konstantinos (Kostas) Kosmatopoulos, MD, PhD, as CEO. Kostas moves from his current role as chief scientific officer. He will use his experience as a medical oncologist and immunologist to lead the company forward during a very active period.
Kostas established Vaxon Biotech in 2004 on the basis of his work as research director at Inserm, France’s national institute of health, and his work specializing in tumor immunotherapy at Institut Gustave Roussy (IGR). The two institutes granted Vaxon Biotech an exclusive worldwide license for three patents. The company subsequently filed seven more patents in its own name.
Kostas received his medical degree at the University of Thessaloniki, his medical oncology certification from Theagenion Cancer Research Institute, Greece, and his PhD in Immunology at Paris XI University, France. Dr. Kosmatopoulos has co-authored more than 50 scientific and international publications.
Other news from the department people

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.